US Patent 12,371,498 — assignment history and current owner

US 12,371,498 · Application 16/959,425

Novel Combination And Use Of Antibodies

Who owns US Patent 12,371,498?

US12371498 ("Novel Combination And Use Of Antibodies") — current assignee: BIOINVENT INTERNATIONAL AB. Status: Active, estimated expiration September 3, 2042. 2 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,371,498 is BIOINVENT INTERNATIONAL AB. Based on the most recent ownership transfer record (recorded 2020-10-19).

Patent title
Novel Combination And Use Of Antibodies
Application number
16/959,425
Apparent operating assignee
BIOINVENT INTERNATIONAL AB
Patent status
Active, estimated expiration September 3, 2042
Recorded assignments
2

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Jul 22, 2020Oct 19, 2020Ownership TransferBEERS, STEPHEN; CRAGG, MARK; ROGHANIAN, ALI; OLDHAM, ROBERTUNIVERSITY OF SOUTHAMPTON54095/222
Aug 4, 2020Oct 19, 2020Ownership TransferFRENDÉUS, BJÖRN; MÅRTENSSON, LINDA; TEIGE, INGRIDBIOINVENT INTERNATIONAL AB54095/58

Scrolls sideways on narrow screens

Chain of title

In 2020, BEERS, STEPHEN; CRAGG, MARK (+2 more) assigned the patent to UNIVERSITY OF SOUTHAMPTON. The most recent ownership transfer, recorded in 2020, lists BIOINVENT INTERNATIONAL AB as assignee.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 16/959,425 · US 12,371,498

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,371,498, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.